“Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S2, https://doi.org/10.25251/skin.3.supp.2.